Sarepta Therapeutics (SRPT) EPS (Diluted) (QoQ) (2010 - 2026)
Sarepta Therapeutics (SRPT) EPS (Diluted) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196.08% |
| Dec 31, 2025 | -57.39% |
| Sep 30, 2025 | -197.19% |
| Jun 30, 2025 | 140.18% |
| Mar 31, 2025 | -412.24% |
| Dec 31, 2024 | 339.94% |
| Sep 30, 2024 | 387.86% |
| Jun 30, 2024 | -81.40% |
| Mar 31, 2024 | -25.10% |
| Dec 31, 2023 | 206.90% |
| Sep 30, 2023 | -70.72% |
| Jun 30, 2023 | 95.40% |
| Mar 31, 2023 | -255.79% |
| Dec 31, 2022 | 100.13% |
| Sep 30, 2022 | -11.19% |
| Jun 30, 2022 | -119.76% |
| Mar 31, 2022 | -79,885.06% |
| Dec 31, 2021 | 99.75% |
| Sep 30, 2021 | -58,942.12% |
| Jun 30, 2021 | 51.51% |